TABLE 3.
Early Follow-Up (≤6 Months) |
Late Follow-Up (>6 Months) |
|||||||
---|---|---|---|---|---|---|---|---|
No. Events | Rate (Per 100 Person-Years) | Attrition, aHR* (95% CI) | P | No. Events | Rate (Per 100 Person-Years) | Attrition, aHR* (95% CI) | P | |
Clinic model | ||||||||
Vertical | 1488 | 57.70 | 1.00 (ref) | 0.87 | 431 | 15.13 | 1.00 (ref) | 0.03 |
Integrated | 1226 | 55.37 | 0.97 (0.71 to 1.33) | 430 | 21.83 | 1.75 (1.04 to 2.94) | ||
Clinic location | ||||||||
Rural | 996 | 60.02 | 1.00 (ref) | 0.30 | 401 | 23.02 | 1.00 (ref) | 0.02 |
Urban | 1721 | 58.83 | 0.84 (0.61 to 1.17) | 459 | 14.94 | 0.57 (0.35 to 0.91) | ||
Clinic experience | ||||||||
First 6 months | 150 | 76.00 | 1.00 (ref) | 0.08 | — | — | — | — |
Post first 6 months | 2558 | 55.79 | 0.71 (0.49 to 1.04) | — | — | — |
Early attrition—fFirst 6 months of patient follow-up; late attrition—post first 6 months of patient follow-up.
Adjusted for pre-ART CD4 count, WHO stage, age, education, and pharmacy staff burden; CD4 count, education, and pharmacy staff burden allowed to have time time-varying effects in early/late follow-up.